These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18424786)

  • 21. Management of diabetes in patients with chronic kidney disease.
    Ahmed Z; Simon B; Choudhury D
    Postgrad Med; 2009 May; 121(3):52-60. PubMed ID: 19491540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
    Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hypertension in chronic heart failure.
    Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of the glucometabolic status assessed in a metabolically stable phase after a first acute myocardial infarction: the SHEEP study.
    Janszky I; Hallqvist J; Ljung R; Ahlbom A; Hammar N
    J Intern Med; 2009 Apr; 265(4):465-75. PubMed ID: 19019187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a scientific review. I. Introduction.
    Carneiro AV
    Rev Port Cardiol; 2008 Jun; 27(6):851-6. PubMed ID: 18751512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA; Valiquette G; Schwarcz MD
    Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure and new drugs: should we be aware?
    Barrios V; Melgarejo E; Escobar C
    Int J Clin Pract; 2009 Sep; 63(9):1392. PubMed ID: 19691625
    [No Abstract]   [Full Text] [Related]  

  • 30. [Heart failure with thiazolidinedione treatment: what do we know today?].
    Erdmann E
    Dtsch Med Wochenschr; 2009 Jan; 134(4):154-8. PubMed ID: 19148858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure.
    Kosiborod M; Inzucchi SE; Spertus JA; Wang Y; Masoudi FA; Havranek EP; Krumholz HM
    Circulation; 2009 Apr; 119(14):1899-907. PubMed ID: 19332465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addressing insulin resistance in Type 1 diabetes.
    Pang TT; Narendran P
    Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M; Dickstein K; Vicenzi M; Arena R
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Bell DS
    Acta Diabetol; 2009 Jun; 46(2):155; author reply 157. PubMed ID: 19300899
    [No Abstract]   [Full Text] [Related]  

  • 38. [Insulin therapy may hasten congestive heart failure in cardiac patients: case series and review of the literature].
    Cosmi F; Cosmi D; Savino K; Ambrosio G
    G Ital Cardiol (Rome); 2008 Jul; 9(7):509-12. PubMed ID: 18678218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic heart disease.
    Marwick TH
    Postgrad Med J; 2008 Apr; 84(990):188-92. PubMed ID: 18424575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of obesity on the risk of heart failure and its prognosis.
    Artham SM; Lavie CJ; Patel HM; Ventura HO
    J Cardiometab Syndr; 2008; 3(3):155-61. PubMed ID: 18983332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.